180 related articles for article (PubMed ID: 24697184)
21. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
Alvarado HL; Abrego G; Garduño-Ramirez ML; Clares B; Calpena AC; García ML
Nanomedicine; 2015 Apr; 11(3):521-30. PubMed ID: 25659643
[TBL] [Abstract][Full Text] [Related]
22. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
Aditya N; Ravi PR; Avula US; Vats R
J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation.
Zhang Z; Xu L; Chen H; Li X
J Pharm Pharmacol; 2014 Apr; 66(4):557-63. PubMed ID: 24635557
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
Calvo P; Vila-Jato JL; Alonso MJ
J Pharm Sci; 1996 May; 85(5):530-6. PubMed ID: 8742946
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone.
Gaafar PM; Abdallah OY; Farid RM; Abdelkader H
J Liposome Res; 2014 Sep; 24(3):204-15. PubMed ID: 24484536
[TBL] [Abstract][Full Text] [Related]
27. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
28. Cationic nanocapsule suspension as an alternative to the sublingual delivery of nifedipine.
Osmari BF; Medeiros GA; Reolon JB; Prado VC; Brucker N; Cruz L
Pharm Dev Technol; 2023 Jun; 28(5):403-413. PubMed ID: 37078702
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
[TBL] [Abstract][Full Text] [Related]
30. Characterization of rheology and release profiles of olanzapine-loaded lipid-core nanocapsules in thermosensitive hydrogel.
Dimer FA; Pohlmann AR; Guterres SS
J Nanosci Nanotechnol; 2013 Dec; 13(12):8144-53. PubMed ID: 24266207
[TBL] [Abstract][Full Text] [Related]
31. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Verma P; Gupta RN; Jha AK; Pandey R
Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
[TBL] [Abstract][Full Text] [Related]
32. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension.
Bucolo C; Maltese A; Puglisi G; Pignatello R
Ophthalmic Res; 2002; 34(5):319-23. PubMed ID: 12381895
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V
Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446
[TBL] [Abstract][Full Text] [Related]
34. [Study on the release of oleanolic acid loaded nanocapsules in vitro].
Huang Y; Li Y; Li XZ; Liu S; Lei P; Xiao J
Zhong Yao Cai; 2008 Feb; 31(2):283-5. PubMed ID: 18619279
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
Limayem Blouza I; Charcosset C; Sfar S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
[TBL] [Abstract][Full Text] [Related]
36. Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.
Fontana MC; Beckenkamp A; Buffon A; Beck RC
Int J Nanomedicine; 2014; 9():2979-91. PubMed ID: 24971009
[TBL] [Abstract][Full Text] [Related]
37. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
[TBL] [Abstract][Full Text] [Related]
38. Preparation and in vitro release of zein microparticles loaded with prednisolone for oral delivery.
Lau ET; Johnson SK; Mikkelsen D; Halley PJ; Steadman KJ
J Microencapsul; 2012; 29(7):706-12. PubMed ID: 22612552
[TBL] [Abstract][Full Text] [Related]
39. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
[TBL] [Abstract][Full Text] [Related]
40. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.
Frank LA; Sandri G; D'Autilia F; Contri RV; Bonferoni MC; Caramella C; Frank AG; Pohlmann AR; Guterres SS
Int J Nanomedicine; 2014; 9():3151-61. PubMed ID: 25061292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
